Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant bicalutamide before and during radiation therapy for intermediate-risk localized prostate cancer
ISRCTN64733264Phase 3Completed
- Sponsor
- Princess Margaret Cancer Centre
- Start
- Jul 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bicalutamide in prostate cancer (PCa) (2 arms), sponsored by Princess Margaret Cancer Centre. Started Jul 1999; status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ISRCTN64733264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64733264.